BRTX vs HAL · rev $401.0K vs P/E 9.3, $19.05B cap
BioRestorative Therapies Inc (BRTX) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
HAL does not have a complete income-statement cache yet.
BRTX currently screens at market cap $10.2M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the BRTX and HAL stock pages for the full models.
Not investment advice.